Polypharmacy in patients with multiple sclerosis and the impact on levels of care and therapy units

BackgroundThe aim of this study was to examine the societal costs of polypharmacy in patients with multiple sclerosis (MS). We therefore focused on the association between the number of medications on the level of care (LOC), the German classification of the need for care, and the number of therapy...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Finn Brüggemann, Stefan Gross, Marie Süße, Pavel Hok, Sebastian Strauss, Tjalf Ziemssen, Niklas Frahm, Uwe K. Zettl, Matthias Grothe
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2023-12-01
Saila:	Frontiers in Neurology
Gaiak:	multiple sclerosis polypharmacy health costs level of care comorbidity
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1330066/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!